摘要
目的:分析我院血必净注射液的不合理用药情况,为临床合理用药提供参考。方法:采用回顾性研究方法,收集2016–2017年我院使用该药的病例,共计1078例,从用药科室、适应证、疗程、给药剂量、溶媒和溶媒量、给药频次、滴速、冲管等方面进行统计分析。结果:1078例中适应证不适宜53.15%、给药剂量不适宜0.93%、溶媒量不适宜25.32%、给药频次不适宜29.59%、未标注滴速98.42%、未冲管70.22%;用药科室主要集中在ICU、急诊病房及呼吸科等。结论:应严格按药品说明书规定使用血必净注射液并加强临床干预,促进合理用药。
Objective: To analyze the irrational application of Xuebijing injection in our hospital and provide references for rational drug use. Methods: Data of 1078 patients who were treated by Xuebijing injection in our hospital from 2016 to 2017 were collected and retrospectively analyzed in terms of the administration department, indication, course of treatment, dosages, solvent, amount of solvent, frequency of administration, drip speed, flushing or not, etc. Results: Among the 1078 cases, the proportion of cases with unreasonable indication, unreasonable dose, unreasonable amount of solvent, unreasonable frequency of administration, unmarked drip speed and unflushed tube was 53.15%, 0.93%, 25.32%, 29.59%, 98.42% and 70.22% respectively. Xuebijing injection was mainly used in the department of intensive care unit (ICU), emergency ward and respiratory department, etc. Conclusion: Xuebijing injection should be used strictly according to the drug instruction, and clinical intervention should be strengthened to promote rational drug use.
作者
崔海珍
于倩
王华
CUI Hai-zhen;YU Qian;WANG Hua(Department of Pharmacy, China-Japan Union Hospital of Jilin University, Changchun 130033, China)
出处
《中国药物应用与监测》
CAS
2019年第2期100-103,共4页
Chinese Journal of Drug Application and Monitoring
基金
吉林省食品药品安全监测中心科技项目(2015474)
关键词
血必净注射液
评价
合理用药
Xuebijing injection
Evaluation
Rational drug use
